ADMA Biologics, Inc. Return on Assets (ROA) for the Trailing 12 Months (TTM) ending September 30, 2021: -32.53%

ADMA Biologics, Inc. Return on Assets (ROA) is -32.53% for the Trailing 12 Months (TTM) ending September 30, 2021, a -12.57% change year over year. Return on assets measures profitability against assets; higher ROA indicates efficient asset use and profitability.
  • ADMA Biologics, Inc. Return on Assets (ROA) for the Trailing 12 Months (TTM) ending September 30, 2020 was -37.21%, a -25.24% change year over year.
  • ADMA Biologics, Inc. Return on Assets (ROA) for the Trailing 12 Months (TTM) ending September 30, 2019 was -49.78%.
Key Data
Date Return on Assets (ROA) Revenue Per Share Free Cash Flow Per Share Dividend Per Share